Search results

Den här artikeln är över 5 år gammal, och informationen kan därför vara inaktuell. Alzheimers sjukdom kännetecknas av onormal spridning och ansamling av proteinet tau i hjärnan. En internationell studie visar nu hur tau sprids enligt fyra distinkta mönster som leder till olika symtom med olika prognoser för de drabbade individerna. Studien publiceras i Nature Medicine. – Till skillnad mot hur vi h

https://www.medicin.lu.se/artikel/ny-studie-alzheimers-sjukdom-fyra-distinkta-subtyper - 2026-05-13

Alzheimers sjukdom kännetecknas av onormal spridning och ansamling av proteinet tau i hjärnan. En internationell studie visar nu hur tau sprids enligt fyra distinkta mönster som leder till olika symtom med olika prognoser för de drabbade individerna. Studien publiceras i Nature Medicine. – Till skillnad mot hur vi hittills tolkat spridningen av tau i hjärnan, visar fynden från denna studie att tau

https://www.lu.se/artikel/ny-studie-alzheimers-sjukdom-fyra-distinkta-subtyper - 2026-05-14

B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill. Uncovering how they form and are ‘programmed’ during development is key to better understanding the immune response to infections and vaccinations. A new study by researchers from Lund University in Sweden provides new insights into the origin and develo

https://www.medicine.lu.se/article/how-b-cells-are-programmed-early-life-can-impact-long-term-immune-health - 2026-05-13

B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill. Uncovering how they form and are ‘programmed’ during development is key to better understanding the immune response to infections and vaccinations. A new study by researchers from Lund Stem Cell Center at Lund University in Sweden provides new insights i

https://www.stemcellcenter.lu.se/article/how-b-cells-are-programmed-early-life-can-impact-long-term-immune-health - 2026-05-13

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.medicine.lu.se/article/update-on-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2026-05-13

In an infection, there are tens of thousands of peptides that provide a wealth of information about which bacteria have caused the infection and how severe it is. A research team at Lund University has now combined clinical questions with mathematical methods to systematically analyze these peptides. This scientific breakthrough has the potential to transform the diagnosis and treatment of infecti

https://www.medicine.lu.se/article/faster-detection-dangerous-infections - 2026-05-13

It has previously been difficult to identify DNA mutations in sperm, as these changes are rare, and most sequencing techniques have a large margin of error. Now a research study led from Lund University, have conducted a pilot study in which they examined sperm DNA and it’s similarity to mutations in children, using the advanced technique called duplex sequencing. Nearly 80 percent of all new muta

https://www.medicine.lu.se/article/new-method-enables-identification-mutations-sperm - 2026-05-13

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.multipark.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2026-05-13

On May 29th, the Helsingborg Innovation District, a collaboration platform and catalyst for innovation, research, and development, will be inaugurated. The innovation district is initiated by the City of Helsingborg, Lund University, Region Skåne, and the Chamber of Commerce and Industry of Southern Sweden in collaboration with the business community. The district stretches from Helsingborg Centra

https://www.ch.lu.se/en/article/new-innovation-district-increase-regions-innovative-capacity - 2026-05-13

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2026-05-13

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-05-13

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.multipark.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-05-13

This article is over 5 years old, and the information may therefore be outdated. “Education and knowledge are the way to change society for the better. I want to make a difference and help to give young people the same fantastic opportunities I had”, says alumna Monica Getz Silfverschöld, a new board member for the Lund University Foundation (LUF). LUF is an independent foundation that aims to str

https://www.staff.lu.se/article/dedicated-alumna-launched-minnesota-model-sweden - 2026-05-13

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.medicine.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-05-13

Anorexia nervosa is a serious psychiatric disorder for which there are limited treatment options, and it has one of the highest mortality rates of any psychiatric diagnosis. A pilot study is now underway at Lund University in Sweden, where researchers are investigating whether psychedelic drugs have an effect on young patients with the disorder. Ward Five at the adult psychiatric clinic in Lund is

https://www.medicine.lu.se/article/psychedelics-treatment-anorexia-new-pilot-study - 2026-05-13

Three research groups at Lund University Diabetes Centre receive new project grants within precision medicine. The aim with the projects is to develop individualised treatment strategies that may benefit people with type 2 diabetes. One of the new projects will investigate whether it is possible to develop individualised treatment strategies for people with type 2 diabetes. The project EPIPREDIA i

https://www.medicine.lu.se/article/precision-medicine-research-within-type-2-diabetes-and-dementia-receives-support - 2026-05-13

Bone and skeletal injuries cause extensive and long-term functional impairments worldwide. In a new study, researchers at Lund University in Sweden show how a cell-free cartilage structure can safely guide bone repair without triggering strong immune responses. The transplant has been successfully tested in animal models, and the next step is to evaluate the tissue engineering approach in humans.

https://www.medicine.lu.se/article/universal-method-could-transform-future-bone-transplantation - 2026-05-13

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.medicine.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-05-13

The Nature Medicine Commission on Data-Driven Obesity Management will bring together global experts and datasets to tackle the growing burden of obesity-related noncommunicable diseases through data-driven decision support. “Our goal is to generate evidence that supports better and more equitable care for people living with obesity worldwide,” says the Commission Chair and Professor Paul Franks at

https://www.medicine.lu.se/article/lund-university-professor-lead-nature-medicine-commission-data-driven-obesity-management - 2026-05-13

An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in Immunity, could pave the way for more precise and personalised cancer immunotherapies. The team has taken an important step toward harnessing the immune system to fight cancer. Their work describes how

https://www.stemcellcenter.lu.se/article/scientists-uncover-cellular-toolkit-reprogram-immune-cells-cancer-therapy - 2026-05-13